Publication | Closed Access
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
577
Citations
33
References
2005
Year
Crohn ’GastroenterologyPlacebo-controlled TrialClinical GastroenterologyUlcerative ColitisCertolizumab PegolMedicineDigestive System Diseases
| Year | Citations | |
|---|---|---|
Page 1
Page 1